14 completed, 3 recruiting, 2 not yet recruiting, 2 unknown. 21 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 21 | Completed 14, Recruiting 3, Not yet recruiting 2, Unknown 2 |
Follow Gastritis: new trials by email Literature Review of Gastritis trials Research Report on Gastritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vonoprazan High-Dose Dual VS Levofloxacin Concomitant Vonoprazan, Levofloxacin 500mg - Helicobacter Pylori Infection, Peptic Ulcer Disease | Phase 4 | Not yet recruiting | Damascus Hospital | 150 | 2026-11-01 | 2026-06-03 |
| Phase 4 Study of Sto M Tab. in Acute or Chronic Gastritis Stillen Tab., Sto M Tab. - Gastritis, Acute Gastritis | Phase 4 | Not yet recruiting | Mather's Pharm. Co., Ltd. | 470 | 2026-06-01 | 2026-06-05 |
| Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment Bismuth, Esomeprazole, Tetracycline - Gastritis, Dyspepsia | Phase 4 | Recruiting | Yongquan Shi | 1248 | 2025-10-28 | 2025-12-02 |
| Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial Vonoprazan, Tetracycline 500mg tid, Minocycline - Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer | Phase 4 | Recruiting | Yongquan Shi | 400 | 2025-04-01 | 2025-08-14 |
| Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology Esomeprazole, Amoxicillin, Bismuth - Gastritis, Dyspepsia | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 124 | 2022-12-01 | 2025-07-03 |
| Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis Mucotra SR Tablet 150mg, Axid Capsule 150mg - Gastritis | Phase 4 | Completed | Daewoong Pharmaceutical Co. LTD. | 260 | 2021-09-30 | 2024-07-01 |
| Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy Esomeprazole, Amoxicillin, Bismuth - Gastritis, Dyspepsia | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 658 | 2020-12-20 | 2023-01-31 |
| Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy Clostridium butyricum capsule, esomeprazole, amoxicillin - Gastritis, Peptic Ulcer | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 600 | 2020-05-05 | 2022-02-11 |
| Helicobacter Pylori Eradication With Clostridum Butyricum Capsule and Bacillus Coagulans Tablets Clostridum Butyricum Capsule, Bacillus Coagulans Tablets, Clostridum Butyricum Capsule plus Bacillus Coagulans Tablets - Gastritis, H Pylori Infection | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 150 | 2019-03-01 | 2019-09-25 |
| Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy Berberine, Amoxicillin, Esomeprazole - Gastric Ulcer, Chronic Gastritis | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 658 | 2018-08-01 | 2019-08-30 |
| Concomitant Versus Hybrid Regimen for H. Pylori Eradication 10 day concomitant regimen, 14 day hybrid regimen - H.Pylori Infection, H.Pylori Gastrointestinal Disease | Phase 4 | Completed | Alexandra Hospital, Athens, Greece | 345 | 2018-02-21 | 2021-08-31 |
| Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy Berberine, clarithromycin, Bismuth - Gastritis, Peptic Ulcer | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 566 | 2015-12-01 | 2017-01-18 |
| Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention ALBIS, Placebo - Gastritis, Gastroduodenal Ulcer | Phase 4 | Completed | Young-Hak Kim, MD, PhD | 47 | 2015-01-21 | 2023-03-22 |
| Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy Berberine, Bismuth, esomeprazole - Gastritis, Peptic Ulcer | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 612 | 2014-11-01 | 2015-09-03 |
| Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia Rebamipide, Placebo (for Esomeprazole), Esomeprazole - Dyspepsia | Phase 4 | Unknown | University of Malaya | 200 | 2014-08-01 | 2016-01-05 |
| Concomitant Therapy of H. Pylori amoxicillin, clarithromycin, metronidazole, rabeprazole - Gastritis, Gastric Ulcer, and Duodenal Ulcer | Phase 4 | Unknown | The Catholic University of Korea | 540 | 2013-08-01 | 2014-02-11 |
| Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality Triple therapy - Helicobacter Pylori Infections, Atrophic Gastritis | Phase 4 | Recruiting | International Agency for Research on Cancer | 30000 | 2013-03-01 | 2025-05-02 |
| Clinical Effect of Rebamipide on Chronic Gastritis Rebamipide, optimization of life style - Gastritis | Phase 4 | Completed | BangMao Wang | 180 | 2012-05-01 | 2015-03-19 |
| To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) Gastropylor Complex Capsules, Placebo Comparator - Chronic Atrophic Gastritis (CAG) | Phase 4 | Completed | Xinjiang Biochemical Pharmaceutical Co., Ltd. | 851 | 2011-08-01 | 2013-07-09 |
| Efficacy and Safety of Probiotic Treatment as a Supportive Therapy in Eradication of H. Pylori Normia, Placebo - Helicobacter Pylori Infection | Phase 4 | Completed | Goran Hauser | 804 | 2008-12-01 | 2013-10-25 |
Showing 20 of 21. Sign in to see all of them.
Peptic Ulcer (10) · Dyspepsia (9) · Stomach Neoplasms (6) · Gastritis, Atrophic (2) · Stomach Ulcer (2) · Duodenal Ulcer (1)
Digestive System Diseases (21) · Gastroenteritis (21) · Gastrointestinal Diseases (21) · Stomach Diseases (21) · Duodenal Diseases (12) · Intestinal Diseases (12) · Pathological Conditions, Signs and Symptoms (9) · Signs and Symptoms (9) · Signs and Symptoms, Digestive (9) · Digestive System Neoplasms (6) · Gastrointestinal Neoplasms (6) · Neoplasms (6) · Neoplasms by Site (6) · Peptic Ulcer (2)
Amoxicillin (9) · Bismuth (8) · Esomeprazole (8) · Clarithromycin (7) · Tetracycline (4) · Berberine (3) · Furazolidone (3) · 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (2) · Metronidazole (2) · rebamipide (2) · DA 9601 (1) · Gastroscopy (1) · Lansoprazole (1) · Levofloxacin (1) · Minocycline (1)
Xijing Hospital of Digestive Diseases (7) · Yongquan Shi (2) · Alexandra Hospital, Athens, Greece (1) · BangMao Wang (1) · Daewoong Pharmaceutical Co. LTD. (1) · Damascus Hospital (1) · Goran Hauser (1) · International Agency for Research on Cancer (1) · Mather's Pharm. Co., Ltd. (1) · The Catholic University of Korea (1) · University of Athens (1) · University of Malaya (1) · Xinjiang Biochemical Pharmaceutical Co., Ltd. (1) · Young-Hak Kim, MD, PhD (1)
China (10) · South Korea (3) · Greece (2) · Croatia (1) · Latvia (1) · Malaysia (1) · Syria (1)
Yongquan Shi, Ph. D (4) · Evangelos J. Giamarellos-Bourboulis, MD, PhD (1) · Goran Hauser, MD,PhD (1) · Jin Young Park, PhD (1) · Kaichun WU, Professor (1) · Marcis Leja, MD, PhD (1) · Myung Kyu Choi (1) · Sanjiv Mahadeva, MRCP, MD (1) · Vassileios Koussoulas, MD, PhD (1) · Wang Bang-mao (1) · Young-Hak Kim, MD (1)
PMID 21633832, PMID 25574111, PMID 28801429, PMID 32348007, PMID 33157939, PMID 34519690, PMID 36193978, PMID 42141850